| MONDAY, MAY 28 |
| 13.00 |
Registration |
| 14.30 |
Meeting Opening |
| 14.30-16.00 |
1st session - HDL genetics
Chairs
S. Calandra (Modena, Italy)
D. Kardassis (Heraklion, Greece) |
| 14.30-15.00 |
Next generation sequening shows that HDL genetics is even more complex than anticipated; what is next?
J.A. Kuivenhoven (Groningen, The Netherlands) |
| 15.00-15.30 |
Using Mendelian randomization to predict causality
A. Tybjaerg-Hansen (Copenhagen, Denmark) |
| 15.30-15.45 |
Mechanisms of ABCA1 gene regulation in the liver
D. Kardassis (Heraklion, Greece) |
| 15.45-16.00 |
Excess of rare non-synonymous gene variants in subjects with extreme levels of HDL-C: analysis of 197 lipid-associated genes
M. Motazacker1, J. Peter1, M. Treskes2, J.A. Kuivenhoven3, G.K. Hovingh1
1(Amsterdam, The Netherlands),
2(Hilversum, The Netherlands),
3(Groningen, The Netherlands) |
| 16.00-16.30 |
Coffee break |
| 16.30-18.15 |
2nd session - HDL functions, Part 1
Chairs
C. Sirtori (Milan, Italy)
A. Remaley (Bethesda, USA) |
| 16.30-17.00 |
HDL, cholesterol efflux capacity and cardiovascular risk
F. Bernini (Parma, Italy) |
| 17.00-17.30 |
Endothelial interctions of HDL
A. von Eckardstein (Zürich, Switzerland) |
| 17.30-17.45 |
Cholesterol efflux and cholesterol loading capacity of sera from patients before and after LDL-apheresis
E. Favari1, M.P. Adorni1 , F. Sbrana2, M. Puntoni2, F. Bigazzi2, F. Zimetti1, F. Bernini1, T. Sampietro2
1(Parma, Italy), 2(Pisa, Italy) |
| 17.45-18.00 |
Effects of inflammatory cytokines on HDL and apoA-I transport through endothelial cells
J. Robert, L. Rohrer, A. von Eckardstein
(Zürich, Switzerland) |
| 18.00-18.15 |
Cyclosporine A impairs the reverse cholesterol transport from macrophages in vivo by reducing sterol fecal excretion
I. Zanotti1, D. Greco1, G. Lusardi1, F. Potì2, F. Bernini1
1(Parma, Italy), 2(Modena, Italy) |
| |
|
| THUESDAY, MAY 29 |
|
